Duk da cewa ana samun sauƙi a yaƙi da cutar hepatitis a duniya, har yanzu ana buƙatar ƙarin ƙoƙari kafin a kai ga burin da aka sa gaba. Rahoton World Health Organization ya nuna cewa ana samun ci gaba, amma ba cikin saurin da ake buƙata ba.
A cewar sabon rahoton, yawan sabbin kamuwa da hepatitis B ya ragu da kashi 32%, yayin da mace-macen da ke da alaƙa da hepatitis C suka ragu da kashi 12%. Wannan yana nufin cewa ƙoƙarin rigakafi da magani suna taimakawa rage yawan masu kamuwa da cutar da kuma mace-mace.
Sai dai duk da wannan ci gaba, cutar hepatitis har yanzu babbar matsala ce ga lafiyar jama’a. A shekarar 2024 kadai, kimanin mutane miliyan 1.34 suka mutu sakamakon cutar, yayin da kusan sabbin kamuwa miliyan 1.8 ke faruwa duk shekara. Gaba ɗaya, kusan mutane miliyan 287 na rayuwa da hepatitis B ko C na dindindin.
Shugaban WHO, Tedros Adhanom Ghebreyesus, ya ce kawar da cutar zai yiwu, amma sai ƙasashe sun ƙara zuba jari a fannin kiwon lafiya tare da jajircewa. Masana sun kuma gargadi cewa ci gaban bai daidaita ba, domin wasu ƙasashe na gaba yayin da wasu ke ja da baya.
A bangaren yara kuwa, an samu babban sauyi mai kyau, domin yawan kamuwa da hepatitis B a tsakanin yara ƙasa da shekaru biyar ya ragu sosai, abin da ke nuna cewa alluran rigakafi suna aiki yadda ya kamata. Duk da haka, babban ƙalubale shi ne magani, domin ƙasa da kashi 5% na masu hepatitis B na dindindin ne ke samun kulawar da suke bukata.
A ƙarshe, sakon ya fito fili: ana samun ci gaba, amma ana buƙatar ƙarin sauri da ƙoƙari musamman wajen gwaji, rigakafi, da samar da magani, domin a iya kawar da cutar hepatitis kafin shekarar 2030.
MAJIYAR LABARI: NEWSTIMEHUB
